The anxiolytic effect of the fear-potentiated startle is not due to a non-specific disruption

Life Sciences

Volumn 63, Issue 25, 1998, Pages 2227-2232

  Joordens, Rosemarie J E ^a   Hijzen, Theo H ^a   Olivier, Berend ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Alprazolam; Anxiety; Chlordiazepoxide; Ethanol; Fear potentiated startle response paradigm; Haloperidol; Rat; Strychnine potentiated startle response paradigm

Indexed keywords

ALCOHOL; ALPRAZOLAM; ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE; HALOPERIDOL; STRYCHNINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATTENUATION; CONTROLLED STUDY; DOSE RESPONSE; FEAR; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RAT; STARTLE REFLEX; TRANQUILIZING ACTIVITY;

ANIMALIA; STRYCHNOS TOXIFERA;

EID: 0032515197     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(98)00507-4     Document Type: Article

References (13)

1. 1. M. DAVIS, W.A. FALLS, S. CAMPEAU, M. KIM, Behav. Brain Res. 58 175-198 (1993).
2. 2. T.H. HIJZEN, S.W.J. HOUTZAGER, R.J.E. JOORDENS, B. OLIVIER, J.L. SLANGEN, Psychopharmacology 118 150-154 (1995).
3. 3. R.J.E. JOORDENS, T.H. HIJZEN, B.W.M.M. PEETERS, B. OLIVIER, Psychopharmacology 126 104-109 (1996).
4. 4. W.K. BERG, M. DAVIS, Physiol. Behav. 32 333-336 (1984).
5. 5. D.J. BILL, A. FLETCHER, B.D. GLENN, M. KNIGHT, Eur. J. Pharmacol. 218 327-334 (1992).
6. 6. R.J.E. JOORDENS, T.H. HIJZEN, B.W.M.M. PEETERS, B. OLIVIER, Neuroreport 8 1031-1034 (1997).
7. 7. P.W. FRANKLAND, J.S. YEOMANS, Behav. Neurosci. 109 669-680 (1995).
8. 8. N.R. SWERDLOW, K.T. BRITTON, Psychopharmacology 115 141-146 (1994).
9. 9. M. DAVIS, Psychopharmacology 62 1-7 (1979).
10. 10. M. DAVIS, Psychopharmacology 95 151-156 (1988).
11. 11. M. DAVIS, Trends Pharmacol. Sci. 13 35-41 (1992).
12. 12. J.H. KEHNE, D.W. GALLAGER, M. DAVIS, Eur. J. Pharamcol. 76 177-186 (1981).
13. 13. M. KOCH, E. FRIAUF Brain Res. 671 63-75 (1995).